Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 29 (RPL23AP29)
- Target
- RPL23AP29
- Molecular classification
- Pseudogene, Retrocopy of ribosomal protein L23a gene
01
Overview
Ribosomal protein L23a pseudogene 29 (RPL23AP29) is a retrocopied pseudogene located on chromosome 4 (chr4:110176778-110176940), derived from the ribosomal protein L23a parental gene. Processed pseudogenes like RPL23AP29 do not encode functional proteins and, unlike canonical ribosomal proteins, are not involved in ribosome assembly, signaling, or cellular processes. There are no reports linking RPL23AP29 to disease, therapeutic intervention, or biomarker relevance. It is important to distinguish this pseudogene from functional ribosomal proteins, particularly RPL23a, which play key roles in translation and have been studied in cancer biology. RPL23AP29 itself, however, has no recognized biological or therapeutic significance.
- Other names
- RPL23A_11_287RPL23AP29
02
Mechanism of action
None; no drugs target this pseudogene
03
Biological functions
No known biological function; as a pseudogene, it is generally not transcribed to functional protein
04
Disease associations
No direct disease roles associated with RPL23AP29; not implicated in any clinical phenotype
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 29 (RPL23AP29).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 29 (RPL23AP29).